Pfizer's (NYSE: PFE) management team is confident in its 2025 opportunities. Where to invest $1,000 right now? Our analyst ...

PFIZER INC (PFE) is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 95% based on the firm’s underlying fundamentals and the stock’s valuation.

Pfizer is an attractive value play, trading at a significant discount despite strong profitability and growth fundamentals ...

According to Benzinga Pro, Pfizer's peer group average for short interest as a percentage of float is 3.60%, which means the ...

PFE stock is trading at trough valuations and at a larger-than-usual discount vs peers. So I think there is some decent margin of safety. Technical analysis vs SPX500 suggests PFE may be forming a ...

With its stock down 7.6% over the past three months ... Check out our latest analysis for Pfizer What Is The Relationship Between ROE And Earnings Growth? So far, we've learned that ROE is ...

UnitedHealth (NYSE:UNH) stock looks attractive - making it a good pick to buy at its current price of around $320.

Meta is expected to report better-than-feared earnings due to an improving digital ad market, making it an appealing stock to buy. • Pfizer’s expected earnings dive and sales decline suggest a more ...

PFE stock –which fell below $21 for the first ... Follow Jesse Cohen on X/Twitter @JesseCohenInv for more stock market analysis and insight.